sofosbuvir

Ligand id: 7368

Name: sofosbuvir

Structure and Physico-chemical Properties

2D Structure
Click here for structure editor
Calculated Physico-chemical Properties
Hydrogen bond acceptors 9
Hydrogen bond donors 3
Rotatable bonds 11
Topological polar surface area 167.99
Molecular weight 529.16
XLogP 1.93
No. Lipinski's rules broken 1

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
Approved drug? Yes (FDA (2013), EMA (2014))
WHO Essential Medicine WHO Model List of Essential Medicines (21st List, 2019). Access PDF version.
IUPAC Name
propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
International Nonproprietary Names
INN number INN
9665 sofosbuvir
Synonyms
GI-7977 | PSI 7977 | Sovaldi®
Comments
Sofosbuvir is a nucleotide analogue whose action inhibits hepatitis C virus (HCV) RNA polymerase.
Sofosbuvir is on the World Health Organisation's List of Essential Medicines. Click here to access the pdf version of the WHO's 21st Essential Medicines list (2019).
Database Links
CAS Registry No. 1190307-88-0 (source: Scifinder)
ChEMBL Ligand CHEMBL1259059
DrugBank Ligand DB08934
GtoPdb PubChem SID 178103940
PubChem CID 45375808
Search Google for chemical match using the InChIKey TTZHDVOVKQGIBA-IQWMDFIBSA-N
Search Google for chemicals with the same backbone TTZHDVOVKQGIBA
Search PubMed clinical trials sofosbuvir
Search PubMed titles sofosbuvir
Search PubMed titles/abstracts sofosbuvir
Search UniChem for chemical match using the InChIKey TTZHDVOVKQGIBA-IQWMDFIBSA-N
Search UniChem for chemicals with the same backbone TTZHDVOVKQGIBA
Wikipedia Sofosbuvir